| Dr Judy L Champaign, MD | |
|
6297 N Fresno St, Fresno, CA 93710-5209 | |
| (559) 325-5876 | |
| Not Available |
| Full Name | Dr Judy L Champaign |
|---|---|
| Gender | Female |
| Speciality | Diagnostic Radiology |
| Experience | 45 Years |
| Location | 6297 N Fresno St, Fresno, California |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043304074 | NPI | - | NPPES |
| G57762 | Other | CA | LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | G57762 (California) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| California Imaging Institute Medical Group Inc | 1951325299 | 29 |
| Central Valley Community Medical Imaging | 5799679874 | 74 |
News Archive
Each year, nearly 120 million units of donated blood flow from donor veins into storage bags at collection centres around the world. The fluid is packed, processed and reserved for later use. But once outside the body, stored red blood cells (RBCs) undergo continuous deterioration. By day 42 in most countries, the products are no longer usable.
SpePharm Holding, BV today announced the acquisition of the worldwide (with the exception of North and South America) rights to Savene® from TopoTarget A/S (Copenhagen, Denmark). As part of the acquisition SpePharm will also take on the European sales force of TopoTarget. Savene®, which has been marketed by TopoTarget since its approval by the EMEA in July 2006, is the only approved product for the treatment of extravasations, or leakage out of the blood stream, of certain commonly used anticancer drugs known as anthracyclines.
Johns Hopkins Medicine researchers say they have developed something akin to a "Google Maps" approach for more accurately computing and visualizing the structural and functional blood vessel changes needed for tumor growth.
Viral Genetics, Inc. today announced that it has changed its name to VG Life Sciences Inc. and that it has completed its 1-for-600 reverse stock split, both of which will take effect at the open of trading on November 27, 2012.
› Verified 6 days ago
| Entity Name | Central Valley Community Medical Imaging |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376637264 PECOS PAC ID: 5799679874 Enrollment ID: O20040210000681 |
News Archive
Each year, nearly 120 million units of donated blood flow from donor veins into storage bags at collection centres around the world. The fluid is packed, processed and reserved for later use. But once outside the body, stored red blood cells (RBCs) undergo continuous deterioration. By day 42 in most countries, the products are no longer usable.
SpePharm Holding, BV today announced the acquisition of the worldwide (with the exception of North and South America) rights to Savene® from TopoTarget A/S (Copenhagen, Denmark). As part of the acquisition SpePharm will also take on the European sales force of TopoTarget. Savene®, which has been marketed by TopoTarget since its approval by the EMEA in July 2006, is the only approved product for the treatment of extravasations, or leakage out of the blood stream, of certain commonly used anticancer drugs known as anthracyclines.
Johns Hopkins Medicine researchers say they have developed something akin to a "Google Maps" approach for more accurately computing and visualizing the structural and functional blood vessel changes needed for tumor growth.
Viral Genetics, Inc. today announced that it has changed its name to VG Life Sciences Inc. and that it has completed its 1-for-600 reverse stock split, both of which will take effect at the open of trading on November 27, 2012.
› Verified 6 days ago
| Entity Name | California Imaging Institute Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497764468 PECOS PAC ID: 1951325299 Enrollment ID: O20060125000531 |
News Archive
Each year, nearly 120 million units of donated blood flow from donor veins into storage bags at collection centres around the world. The fluid is packed, processed and reserved for later use. But once outside the body, stored red blood cells (RBCs) undergo continuous deterioration. By day 42 in most countries, the products are no longer usable.
SpePharm Holding, BV today announced the acquisition of the worldwide (with the exception of North and South America) rights to Savene® from TopoTarget A/S (Copenhagen, Denmark). As part of the acquisition SpePharm will also take on the European sales force of TopoTarget. Savene®, which has been marketed by TopoTarget since its approval by the EMEA in July 2006, is the only approved product for the treatment of extravasations, or leakage out of the blood stream, of certain commonly used anticancer drugs known as anthracyclines.
Johns Hopkins Medicine researchers say they have developed something akin to a "Google Maps" approach for more accurately computing and visualizing the structural and functional blood vessel changes needed for tumor growth.
Viral Genetics, Inc. today announced that it has changed its name to VG Life Sciences Inc. and that it has completed its 1-for-600 reverse stock split, both of which will take effect at the open of trading on November 27, 2012.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Judy L Champaign, MD 1867 E Fir Ave Ste 104, Fresno, CA 93720-3841 Ph: (559) 325-5800 | Dr Judy L Champaign, MD 6297 N Fresno St, Fresno, CA 93710-5209 Ph: (559) 325-5876 |
News Archive
Each year, nearly 120 million units of donated blood flow from donor veins into storage bags at collection centres around the world. The fluid is packed, processed and reserved for later use. But once outside the body, stored red blood cells (RBCs) undergo continuous deterioration. By day 42 in most countries, the products are no longer usable.
SpePharm Holding, BV today announced the acquisition of the worldwide (with the exception of North and South America) rights to Savene® from TopoTarget A/S (Copenhagen, Denmark). As part of the acquisition SpePharm will also take on the European sales force of TopoTarget. Savene®, which has been marketed by TopoTarget since its approval by the EMEA in July 2006, is the only approved product for the treatment of extravasations, or leakage out of the blood stream, of certain commonly used anticancer drugs known as anthracyclines.
Johns Hopkins Medicine researchers say they have developed something akin to a "Google Maps" approach for more accurately computing and visualizing the structural and functional blood vessel changes needed for tumor growth.
Viral Genetics, Inc. today announced that it has changed its name to VG Life Sciences Inc. and that it has completed its 1-for-600 reverse stock split, both of which will take effect at the open of trading on November 27, 2012.
› Verified 6 days ago
David Toshio Nakamura, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 6107 N Fresno St, Fresno, CA 93710 Phone: 858-703-7272 | |
Dr. William J Vlymen, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 1243 E Spruce, Ste 101, Fresno, CA 93720 Phone: 559-439-7226 | |
Dr. Ivan Ramirez, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 1867 E Fir Ave, Suite 104, Fresno, CA 93720 Phone: 559-325-5800 Fax: 559-325-5838 | |
Dr. Puneet Rana, MD, MS Radiology Medicare: Medicare Enrolled Practice Location: 1827 E Fir Ave Ste 101, Fresno, CA 93720 Phone: 559-400-7629 | |
Michael Edward Cody, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 7300 N Fresno St, Fresno, CA 93720 Phone: 559-448-4500 | |
Shushan Petrosyan, RDCS, RDMS, RVT Radiology Medicare: Not Enrolled in Medicare Practice Location: 1095 E Shaw Ave Ste 200a, Fresno, CA 93710 Phone: 559-906-6667 |